What Is Tumoral Thrombosis?

Tumoral thrombosis (also known as tumor thrombus) is a condition that occurs in certain cancers. It happens when a tumor extends into a blood vessel.

Tumoral thrombosis (TT) can significantly worsen a cancer prognosis. It’s a type of thrombosis, which is the formation of a blood clot or blockage in a blood vessel. It can affect any blood vessel but is more common in veins (venous thrombosis).

TT can occur in different types of cancer , such as:

renal cell cancer (RCC) and Wilms’ tumor, which begin in the kidneys
hepatocellular cancer (HCC) that affects your liver
adrenal cortical cancer found in your adrenal glands

pain, skin discoloration, warmth, and swelling, usually somewhere on a leg or arm
chest pain and increased heart rate
breathing issues and lightheadedness

Read on to learn more about tumoral thrombosis — its symptoms, diagnosis, treatment, complications, and other important information.

As cancer grows, it can spread into different tissues and organs. If a blood vessel is near the tumor location, there is a chance that the tumor can grow into it, causing TT. TT may restrict and even completely block the blood flow in this vessel.

Cancers that affect certain organs, such as the kidneys and liver, often develop close to large blood vessels. Researchers estimate that 10% to 18% of people with renal cell cancer will develop TT in one of their renal veins. And 4% to 23% of people with this condition may have TT in their inferior vena cava, the largest vein in the body.

For both workers and companies, employer-sponsored health insurance is costly. For 2018, employers paid an average of $10,000 per employee to cover 70% of the cost of health insurance, leaving workers with a price tag of about $4,200 for the remaining 30% of the expense, CNBC

Risk factors for TT development include having:

certain types of cancer, such as RCC or HCC
large tumors
cancers at an advanced stage
cancers that spread into distant organs (distant metastasis)

TT usually doesn’t have any specific symptoms. But depending on its type and stage, you may experience symptoms of a growing tumor, such as:

lower back or stomach pain
a mass felt inside your stomach
unexplained weight loss
fever

TT can have life threatening complications, including venous thromboembolism (VTE) and major bleeding. In a 2022 study involving 86 people who developed the condition due to kidney cancer, 17 later had VTE, while 11 experienced major bleeding.

Venous thromboembolism

VTE includes different conditions, the most common of which are deep vein thrombosis (DVT) and pulmonary embolism (PE).

DVT can happen when there is a blockage in a deep vein, most often in your arms or legs. PE, on the other hand, happens when this blockage (in the case of TT, a piece of tumor) breaks off from its original location, travels through your bloodstream, and gets stuck in a blood vessel in the lungs.

Major bleeding

Major bleeding can cause death or require a blood transfusion. In people with TT, it can often be a complication of blood thinning therapies used to treat blood clots. Distant metastases can also increase your risk of major bleeding.

Bleeding can be external and internal. Symptoms of internal bleeding include:

dizziness and weakness
decreased consciousness
low blood pressure
trouble seeing
numbness
severe headache
severe stomach pain
shortness of breath
chest pain
nausea
vomiting
diarrhea

Oncologists usually discover TT when doing imaging tests on a tumor. These tests may include:

magnetic resonance imaging (MRI)
computed tomography (CT)
ultrasound
angiography
positron emission tomography (PET) scan
venography

Treatment of TT depends on the type of cancer. Let’s discuss the treatment of TT in kidney and liver cancers.

Kidney cancer

Surgery to remove the tumor is the most common treatment for TT in the kidneys. It can significantly improve your chances of survival. Doctors sometimes use targeted therapies before surgery to reduce tumor size.

Liver cancer

Doctors don’t usually perform surgery to remove liver cancers with TT. This is because liver cancers usually develop in people with cirrhosis. Surgery may further aggravate liver damage, causing liver failure.

Instead, doctors often use selective internal radiation therapy (SIRT) . This procedure involves using high dose radiation delivered precisely to the tumor site. The medications lenvatinib and sorafenib can also help shrink liver tumors with TT.

If you have TT, you’ll likely be under medical observation. Be sure to get immediate medical attention if you notice the following symptoms of VTE, as they can be life threatening:

pain, skin discoloration, warmth, and swelling in the affected area
shortness of breath
chest pain
irregular or increased heart rate
lightheadedness and decreased consciousness

TT in a tumor can significantly worsen a cancer prognosis. Generally, people that have TT developed in kidney cancers have a better prognosis than those who have TT in liver cancers.

However, your outlook will depend on how far the tumor has spread into the blood vessel and other factors. Be sure to speak with a doctor about your outlook.

TT is a condition when a tumor extends into a blood vessel. It can cause serious complications related to obstructed blood flow. This condition may significantly worsen a cancer prognosis.

TT usually doesn’t have specific symptoms. Doctors typically discover it when performing imaging tests on your tumor. Treatment depends on the type and location of your cancer.

Last medically reviewed on March 10, 2023

How we reviewed this article:

Austra Health has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical associations. We avoid using tertiary references. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.

Bertram Quencer K, et al. (2017). Tumor thrombus: Incidence, imaging, prognosis and treatment.
ncbi.nlm.nih.gov/pmc/articles/PMC5778532/
Kaptein FHJ, et al. (2022). Prevalence, treatment, and prognosis of tumor thrombi in renal cell carcinoma.
jacc.org/doi/10.1016/j.jaccao.2022.07.011
Ljungberg B, et al. (2022). Renal cell carcinoma.
uroweb.org/guidelines/renal-cell-carcinoma
Luo F, et al. (2021). The progress in the treatment of hepatocellular carcinoma with portal vein tumor thrombus.
frontiersin.org/articles/10.3389/fonc.2021.635731/full
Marcoux C, et al. (2019). Natural history of tumor thrombus: A single-centre retrospective study.
ashpublications.org/blood/article/134/Supplement_1/2430/422890/Natural-History-of-Tumor-Thrombus-A-Single-Centre
Sundram FX, et al. (2017). Selective internal radiation therapy for liver tumours.
ncbi.nlm.nih.gov/pmc/articles/PMC6301920/